ID   PCI-66
AC   CVCL_5199
DR   cancercelllines; CVCL_5199
DR   Cosmic; 707261
DR   Cosmic; 1066201
DR   Wikidata; Q54938721
RX   PubMed=8797870;
RX   PubMed=11115575;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Hemizygous (PubMed=11115575).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
RX   PubMed=8797870; DOI=10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S;
RA   Kishimoto T., Ishikura H., Kimura C., Takahashi T., Kato H.,
RA   Yoshiki T.;
RT   "Phenotypes correlating to metastatic properties of pancreas
RT   adenocarcinoma in vivo: the importance of surface sialyl Lewis(a)
RT   antigen.";
RL   Int. J. Cancer 69:290-294(1996).
//
RX   PubMed=11115575; DOI=10.3892/or.8.1.89;
RA   Sun C.-L., Yamato T., Furukawa T., Ohnishi Y., Kijima H., Horii A.;
RT   "Characterization of the mutations of the K-ras, p53, p16, and SMAD4
RT   genes in 15 human pancreatic cancer cell lines.";
RL   Oncol. Rep. 8:89-92(2001).
//